100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary of all lectures Medicinal Chemistry and Biophysics $13.47   Add to cart

Summary

Summary of all lectures Medicinal Chemistry and Biophysics

 45 views  3 purchases
  • Course
  • Institution

Summary of all lecture notes of Medicinal Chemistry and Biophysics

Preview 4 out of 79  pages

  • October 27, 2021
  • 79
  • 2021/2022
  • Summary
avatar-seller
Medicinal Chemistry and Biophysics
Lecture 1: Introduction and Thermodynamics
Medicijnen oefenen biologische effecten uit, voor specifieke ziektebeelden is er behoefte aan
specifieke medicijnen.

Medicines are chemicals, interacting with proteins.

Medicines are small molecules:
- NCE: new chemical entities.
- BLA: biologics applications.

Medicinal Chemistry is highly interdisciplinary: Chemistry, Biochemistry, Physics, Biophysics, Biology.

Drug companies want to make money.

Medicinal Chemistry: chemistry plays a key role within the pharmacy. Chemical knowledge is
required to:
- To design and determine the physical/chemical properties of drugs.
- To gain insight into the stability of drugs.
- Absorption and excretion of drugs is partly determined by their chemical properties.
- Metabolism of drugs based is on (bio)chemical transformations.
- The formulation of drugs (administration).
- Quality control of medicines.
- The analysis of drugs and their metabolites.
Biophysics: is the use of light, sound or particle emission (waves) to study a (bio) sample.

Proteins are made of amino acids.

The 3D structure determines the biological activity of drugs:
- Membrane passage.
- Binding to targets.
- Metabolism.
- Pharmacokinetics.

Membranes are made of lipids; water cannot get through. The exterior side is polar, the interior side
is non-polar. Passive membrane passage can be estimated/predicted by the log P value, which is
defined by the physical/chemical properties of the drug. Active transport relies on molecular
recognition (shape) by transport proteins.




PH of solute chosen to generate neutral molecules.
Measure of lipophilicity.

,Lipinski’s rule of five:
- Molecular mass less than 500.
- Log(P) less than 5.
- Less than ten hydrogen bond acceptors (-O-, -N- etc).
- Less than five hydrogen bond donors (NH, OH etc).
The more charged a system → the worse the log(p) → the less effective the drug
→ drug design relays much more on H bonds than on charges
Good absorption requires good solubility in both water and in membranes.

Lipids contain a polar head group and a hydrophobic (non-polar) tail.

Drugs bind to targets:
Paul Ehrlich (1854 – 1915) introduced the idea that the biological effect of almost all compounds was
due to it binding to a target (no alcohol receptor). ‘’Bodies do not act if they are not bound.’’

Lock and key:
- Drugs bind to their target molecules (receptors, enzymes etc.) by the Lock and Key principle
– but the process of binding is dynamic
- First formulated in 1894 by Emil Fisher.
- Example of retinol bound to a transport protein.

Thermodynamics and kinetics: binding is described by the same laws as chemical reactions.
Thermodynamics:
- Describes the equilibrium state.
- Parameter → K.

Kinetics:
- Describes the rate (speed) of the process.
- Parameter → k.




The more stable the products, the more there is present at equilibrium.

Types of interaction:
Covalent:
- Association. →




- Dissociation does not occur.
- No equilibrium, only a (kinetic) rate.

,Non-covalent:




Energetic of drug: target interactions:
- Each new interaction provides a change in (delta G) the Gibbs free energy.
- Gibbs free energy (delta G) is the energy required to build the system from nothing.

For a system to happen: reaction has to move from a high affinity state to a low affinity state.
• Gibbs free energy must drop → larger drop = more successful reaction

Energetics of drug-receptor interactions:




Enthalpy (delta H) and entropy (delta S) are driving forces of a reaction.
Drug design is about making delta G as small as possible (-500).
a.As large as possible (+500) b.As small as possible (-500)

dH = H-bonds
-T x dS = hydrophobics (high in exothermic reaction)

Delta H > 0 (heat) energy is absorbed → reaction is endothermic.
Delta H < 0 (heat) is energy is released → reaction is exothermic.

Delta S (entropy) is a measure of the ordering of the system.
• Entropy up, in exothermic reaction

The speed of the reaction depends on the activation energy.
Negative Gibbs free energy → drugs will bind (heat negative, exothermic, energy release)

, 𝑫𝒆𝒍𝒕𝒂𝑮 = 𝑹 𝒙 𝑻 𝒙 𝒍𝒏(𝑲𝒅)
R = gas constant
T = absolute temperature
Non-covalent binding is achieved by many simultaneous interactions between the ligand and the
macromolecule.

Electrostatic interactions (ion-ion):
- Opposite charges attract. → dependent on distance
- Equal charges repel.
- Typical interaction energy 4-8 kcal/mol.
- Geometry plays an important role.
- Contributes to enthalpy.

Ion-ion dipole:
- Hydrogen bonds; specific orientations that can make H bonds (not distance dependent)
- 1-7 kcal/mol.
- Acceptor: O, N, F.
- Donors: OH and NH.
- Contributes to enthalpy.
- Geometry plays an important role.

Hydrophobic interactions (important for the folding of proteins):
- Entropy (solvation) is the driving force. 1 kcal/mol. Specific fit.
- Assembly with minimal disruption of the solvent.
- Hydrogen bonding networks.
- Contributes to the entropy.
- Geometry is less important.

Role of entropy in Binding:
- Through reduced ligand flexibility → lower entropy.
- Removal of solvation shell around both bindings’ partners → increases entropy.

Single bond in a molecule → free rotation possible: higher level of entropy and higher level of
disorder in solution, can occupy many states
• When its bound, cannot longer move → lost entropy

Contribution of hydrophobic interactions to binding: There is no strong correlation but the trend
seems to be that more 'buried' hydrophobic surface leads to stronger binding.

Enthalpy-entropy compensation: Weaker ionic interactions (ΔH) can be compensated for by
improved hydrophobics (ΔS) and vice versa.
• Smaller dG → molecule binds more tightly
• Smaller -T x dS → adding of hydrophobic constituent

Modifications are cumulative:
- Different optimization routes may lead to the same molecule.
- The effect of two independent substituents is cumulative.
- We refer to a ΔΔG (a change in the ΔG).

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller eliselammers. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.47. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73918 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you


$13.47  3x  sold
  • (0)
  Add to cart